Background: Poorly differentiated neuroendocrine neoplasms (pdNEN) are a rare cancer entity, treatment of which is to a great part informed by studies on the much more common small-cell
Data Description 0 represents no mutation, 1 represents a mutation Survive relates to the survival outcome of the patient. SurviveTime is in days (7300 chosen for alive patients). Ovarian Cancer Pa
Candidate gene studies have become very popular but some of their implicit constraints, such as the familial risk and the population attributable fraction (PAF) conferred by the gene under study, are
BackgroundWhile cancer survival among Aboriginal and Torres Strait Islander peoples has improved over time, they continue to experience poorer cancer survival than other Australians. Key drivers of th
